Martha G. Quinonez, Phr
About Martha G. Quinonez, Phr
Martha G. Quinonez is the Senior Employee Services Programs Admin at Sandia National Laboratories, with a background in Human Resource Management and extensive experience in employee wellness and benefits administration.
Company
Martha G. Quinonez currently works at Sandia National Laboratories. She has held various roles within the organization, including Senior Employee Services Programs Admin since 2018, Employee Health, Services & Benefits Admin from 2017 to 2018, and Employee Health and Services, UnderGrad Student Intern from 2016 to 2017.
Title
Martha G. Quinonez serves as the Senior Employee Services Programs Admin at Sandia National Laboratories. She has been in this role since 2018. In this capacity, she is responsible for managing a portfolio of 10 contracts/vendors and delivering Benefit Orientations to approximately 210 new hires annually.
Education and Expertise
Martha G. Quinonez graduated from California State University-East Bay with a Bachelor's degree in Human Resource Management, completing her studies from 2015 to 2017. She also studied at Las Positas College from 2012 to 2015. Her educational background equips her with skills essential for her roles in employee services and human resources.
Background
Prior to her current role, Martha G. Quinonez worked at Unified Grocers as a Summer Intern in Sales and Marketing in 2012. She later joined Sandia National Laboratories, where she held positions as an UnderGrad Student Intern, Employee Health, Services & Benefits Admin, and ultimately Senior Employee Services Programs Admin.
Achievements
Martha G. Quinonez has led several impactful initiatives at Sandia National Laboratories. In 2018, she implemented a Pet Therapy program to enhance employee wellness. She partnered with Procurement to secure three contracts worth over $1.3 million and led the project management for installing 36 AED units at Sandia’s Livermore site. She also enhanced the Electric Charging Vehicle Program and played a key role in a joint COVID vaccine rollout with Lawrence Laboratories, administering 600 doses to employees between April and May 2021.